Mycophenolate mofetil monotherapy in liver transplantation.
about
Mycophenolate mofetil for liver-transplanted patientsCurrent status of immunosuppression in liver transplantationReduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study.A comprehensive review of immunosuppression used for liver transplantation.Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.The use of mycophenolate mofetil in liver transplant recipients.Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantationImmunosuppression: towards a logical approach in liver transplantation.Mycophenolate mofetil in liver transplantation--is monotherapy safe?Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells.Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.Immunomodulating therapy in liver transplantation: principles and practice.Immunomodulating options for liver transplant patients.Selection and use of immunosuppressive therapies after liver transplantation: current German practice.Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction.Overview of immunosuppression in liver transplantation.Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels.Mycophenolate mofetil can be used as monotherapy late after liver transplantation.Mycophenolate mofetil monotherapy in liver transplant recipients.Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
P2860
Q24242476-A202A8FA-AD66-40F9-BD67-C98648213BD1Q27694591-17D29732-7FE0-4BBE-BA15-2A6BF668437FQ33394798-685413E5-5714-4EC8-B042-F590BC7A6BEAQ33602527-DE294E22-4361-4929-86E2-B843C3319CE0Q34023486-2E8358B3-0E29-4F83-B45E-1C8D42FEB89CQ34093760-15EAF519-69F8-4AB2-A0FC-AE0A32A4067DQ35574966-B429E24A-290D-4F68-B2C9-F62D1DC4B191Q35959103-F3E4E133-E2F1-4BCA-8008-F1549FA91FAEQ35987954-85CADBA9-F8A0-4861-9DA2-ED2FD2763BE6Q36652058-E3E266B4-1F92-4D26-96AE-2A2D7838443FQ37064446-AE440551-A4B4-4E3F-B5C4-C54CB1F72E4FQ37355472-A5056F18-A8F9-4406-B96E-D1207C45476DQ37690527-B201DB33-CC82-4446-B58A-28F9D116F322Q38019054-2C09A6B3-980A-4EED-9F05-938DF0152FF2Q38027593-958E8EB2-F751-4388-AA47-CC07838300F0Q38040507-E5BB87B4-88B4-4280-88AA-0CAB66E0D53EQ38044761-4C8B1029-4A99-4A74-95CC-A37951E79F90Q38726102-89F25680-02FB-4741-BF02-F45836C04DDFQ38757060-7816D6DD-80A5-42DC-B90D-6CA658C9FA9CQ40441702-9368E3BD-A090-4D59-9D92-1BDAE5E9BCA2Q41341000-18B290A2-BEBE-4C6B-AB29-C9F1284CD8BBQ42555714-E00BFEDD-4C4F-4A3E-8F6A-76223E7D8BF0Q43037856-435DF142-789D-4009-B0B0-D12FF66203F1Q43670400-44E99C70-EA1A-4FF2-A97C-00C0978ED820Q45058854-38BA4A0B-967F-4002-9EBB-4188F923D485Q45076857-5999818E-7097-4792-8DB5-5DA1CC1DD7E1Q57791759-04CE83B5-5044-4DE9-B8EE-87B5D44F263B
P2860
Mycophenolate mofetil monotherapy in liver transplantation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Mycophenolate mofetil monotherapy in liver transplantation.
@en
Mycophenolate mofetil monotherapy in liver transplantation.
@nl
type
label
Mycophenolate mofetil monotherapy in liver transplantation.
@en
Mycophenolate mofetil monotherapy in liver transplantation.
@nl
prefLabel
Mycophenolate mofetil monotherapy in liver transplantation.
@en
Mycophenolate mofetil monotherapy in liver transplantation.
@nl
P2093
P1433
P1476
Mycophenolate mofetil monotherapy in liver transplantation.
@en
P2093
P304
P356
10.1016/S0140-6736(00)04065-4
P407
P577
2001-02-01T00:00:00Z